Intrexon | XON - Passivo Circulante





Passivo Circulante Alterar Data
Agenus USD 231.82M 17.42M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 25.5B 547M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
MannKind USD 142.9M 8.34M 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Xencor USD 81.86M 8.41M 2026-06